{"entity":{"type":"insider","cik":"0001879013","url":"/insider/0001879013","json_url":"/insider/0001879013.json","name":"Guyer William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":42,"n_filings":33,"first":"2023-12-22","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Guyer William","source":"filing","n_filings":33,"first_seen":"2023-12-22","last_seen":"2026-08-12"}],"transactions":[{"id":9255433,"accession":"0001193125-26-346942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-346942","line_url":"/filing/0001193125-26-346942","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16300.0,"shares_display":"16,300","price_per_share":113.42883944785277,"price_display":"113.43","price_state":"stated","total_value":1848890.083,"total_display":"1,848,890.08","total_whole":"1,848,890","shares_owned_after":8755.0,"shares_owned_after_display":"8,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider","n_lines":2},{"id":6073857,"accession":"0001193125-26-338637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-338637","line_url":"/filing/0001193125-26-338637#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":113.1248,"price_display":"113.12","price_state":"stated","total_value":418561.76,"total_display":"418,561.76","total_whole":"418,562","shares_owned_after":3985.0,"shares_owned_after_display":"3,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-04","filed_date":"2026-08-06","scope":"insider"},{"id":5860007,"accession":"0001193125-26-298865","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-298865","line_url":"/filing/0001193125-26-298865","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":93.12648224,"price_display":"93.13","price_state":"stated","total_value":1862529.6448,"total_display":"1,862,529.64","total_whole":"1,862,530","shares_owned_after":4937.0,"shares_owned_after_display":"4,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-08","scope":"insider","n_lines":2},{"id":6017801,"accession":"0001193125-26-257618","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-257618","line_url":"/filing/0001193125-26-257618#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":70.6,"price_display":"70.60","price_state":"stated","total_value":1412000.0,"total_display":"1,412,000.00","total_whole":"1,412,000","shares_owned_after":3985.0,"shares_owned_after_display":"3,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-04","scope":"insider"},{"id":5749417,"accession":"0001193125-26-212118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-212118","line_url":"/filing/0001193125-26-212118#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":51.83,"price_display":"51.83","price_state":"stated","total_value":1036600.0,"total_display":"1,036,600.00","total_whole":"1,036,600","shares_owned_after":2231.0,"shares_owned_after_display":"2,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-07","scope":"insider"},{"id":5894235,"accession":"0001193125-26-148497","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-148497","line_url":"/filing/0001193125-26-148497#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.97,"price_display":"40.97","price_state":"stated","total_value":819400.0,"total_display":"819,400.00","total_whole":"819,400","shares_owned_after":2231.0,"shares_owned_after_display":"2,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-08","scope":"insider"},{"id":5762693,"accession":"0001193125-26-122136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-122136","line_url":"/filing/0001193125-26-122136#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11767.0,"shares_display":"11,767","price_per_share":36.01,"price_display":"36.01","price_state":"stated","total_value":423729.67,"total_display":"423,729.67","total_whole":"423,730","shares_owned_after":2231.0,"shares_owned_after_display":"2,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-20","filed_date":"2026-03-24","scope":"insider"},{"id":5904875,"accession":"0001193125-26-096653","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-096653","line_url":"/filing/0001193125-26-096653#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8233.0,"shares_display":"8,233","price_per_share":35.9949,"price_display":"35.99","price_state":"stated","total_value":296346.0117,"total_display":"296,346.01","total_whole":"296,346","shares_owned_after":2231.0,"shares_owned_after_display":"2,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":5943341,"accession":"0001193125-26-039717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-039717","line_url":"/filing/0001193125-26-039717#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.8667,"price_display":"40.87","price_state":"stated","total_value":817334.0,"total_display":"817,334.00","total_whole":"817,334","shares_owned_after":1235.0,"shares_owned_after_display":"1,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-05","scope":"insider"},{"id":5782011,"accession":"0001193125-26-008023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-008023","line_url":"/filing/0001193125-26-008023#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":35.1828,"price_display":"35.18","price_state":"stated","total_value":703656.0,"total_display":"703,656.00","total_whole":"703,656","shares_owned_after":1235.0,"shares_owned_after_display":"1,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":4135614,"accession":"0001193125-25-307282","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-25-307282","line_url":"/filing/0001193125-25-307282","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":80.0763032,"price_display":"80.08","price_state":"stated","total_value":1601526.064,"total_display":"1,601,526.06","total_whole":"1,601,526","shares_owned_after":1875.0,"shares_owned_after_display":"1,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-03","scope":"insider","n_lines":2},{"id":9255153,"accession":"0001193125-25-307194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-307194","line_url":"/filing/0001193125-25-307194#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":80.9045,"price_display":"80.90","price_state":"stated","total_value":364070.25,"total_display":"364,070.25","total_whole":"364,070","shares_owned_after":787.0,"shares_owned_after_display":"787","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-12-03","scope":"insider"},{"id":4880190,"accession":"0001193125-25-300821","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-300821","line_url":"/filing/0001193125-25-300821#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":80.9045,"price_display":"80.90","price_state":"stated","total_value":364070.25,"total_display":"364,070.25","total_whole":"364,070","shares_owned_after":787.0,"shares_owned_after_display":"787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4845799,"accession":"0001193125-25-272572","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-272572","line_url":"/filing/0001193125-25-272572","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":75.35608482,"price_display":"75.36","price_state":"stated","total_value":1507121.6964,"total_display":"1,507,121.70","total_whole":"1,507,122","shares_owned_after":5587.0,"shares_owned_after_display":"5,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-07","scope":"insider","n_lines":3},{"id":4202076,"accession":"0001193125-25-236107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-236107","line_url":"/filing/0001193125-25-236107#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":89.9391,"price_display":"89.94","price_state":"stated","total_value":1798782.0,"total_display":"1,798,782.00","total_whole":"1,798,782","shares_owned_after":5287.0,"shares_owned_after_display":"5,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-09","scope":"insider"},{"id":4229740,"accession":"0001193125-25-196319","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-196319","line_url":"/filing/0001193125-25-196319","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":70.49241274,"price_display":"70.49","price_state":"stated","total_value":1409848.2548,"total_display":"1,409,848.25","total_whole":"1,409,848","shares_owned_after":9893.0,"shares_owned_after_display":"9,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider","n_lines":2},{"id":4795534,"accession":"0001193125-25-179180","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-179180","line_url":"/filing/0001193125-25-179180#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35007.0,"shares_display":"35,007","price_per_share":71.77,"price_display":"71.77","price_state":"stated","total_value":2512452.39,"total_display":"2,512,452.39","total_whole":"2,512,452","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-08","filed_date":"2025-08-12","scope":"insider"},{"id":4751480,"accession":"0000950170-25-105330","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-105330","line_url":"/filing/0000950170-25-105330#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14.0,"shares_display":"14","price_per_share":71.77,"price_display":"71.77","price_state":"stated","total_value":1004.78,"total_display":"1,004.78","total_whole":"1,005","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-05","filed_date":"2025-08-07","scope":"insider"},{"id":4063186,"accession":"0000950170-25-097370","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-097370","line_url":"/filing/0000950170-25-097370#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":73.442,"price_display":"73.44","price_state":"stated","total_value":36721.0,"total_display":"36,721.00","total_whole":"36,721","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-18","filed_date":"2025-07-21","scope":"insider"},{"id":4063181,"accession":"0000950170-25-097370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-097370","line_url":"/filing/0000950170-25-097370#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4379.0,"shares_display":"4,379","price_per_share":73.4811,"price_display":"73.48","price_state":"stated","total_value":321773.7369,"total_display":"321,773.74","total_whole":"321,774","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-21","scope":"insider"},{"id":4048857,"accession":"0000950170-25-094123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-094123","line_url":"/filing/0000950170-25-094123#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":73.505,"price_display":"73.50","price_state":"stated","total_value":7350.5,"total_display":"7,350.50","total_whole":"7,351","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-03","scope":"insider"},{"id":4946875,"accession":"0000950170-25-085755","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-085755","line_url":"/filing/0000950170-25-085755","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":72.4237285,"price_display":"72.42","price_state":"stated","total_value":1448474.57,"total_display":"1,448,474.57","total_whole":"1,448,475","shares_owned_after":8569.0,"shares_owned_after_display":"8,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-12","scope":"insider","n_lines":2},{"id":4418185,"accession":"0000950170-25-075484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-075484","line_url":"/filing/0000950170-25-075484#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32262.0,"shares_display":"32,262","price_per_share":74.1744,"price_display":"74.17","price_state":"stated","total_value":2393014.4928,"total_display":"2,393,014.49","total_whole":"2,393,014","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":4235644,"accession":"0000950170-25-067451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-067451","line_url":"/filing/0000950170-25-067451#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7060.0,"shares_display":"7,060","price_per_share":74.3134,"price_display":"74.31","price_state":"stated","total_value":524652.604,"total_display":"524,652.60","total_whole":"524,653","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-06","filed_date":"2025-05-08","scope":"insider"},{"id":4048231,"accession":"0000950170-25-049800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-049800","line_url":"/filing/0000950170-25-049800#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":678.0,"shares_display":"678","price_per_share":114.5118,"price_display":"114.51","price_state":"stated","total_value":77639.0004,"total_display":"77,639.00","total_whole":"77,639","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-02","scope":"insider"},{"id":4263686,"accession":"0000950170-25-032747","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-032747","line_url":"/filing/0000950170-25-032747#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":59.07,"price_display":"59.07","price_state":"stated","total_value":1181400.0,"total_display":"1,181,400.00","total_whole":"1,181,400","shares_owned_after":5487.0,"shares_owned_after_display":"5,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":2467223,"accession":"0000950170-24-121742","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-121742","line_url":"/filing/0000950170-24-121742#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3394.0,"shares_display":"3,394","price_per_share":48.97,"price_display":"48.97","price_state":"stated","total_value":166204.18,"total_display":"166,204.18","total_whole":"166,204","shares_owned_after":5796.0,"shares_owned_after_display":"5,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-05","scope":"insider"},{"id":2467217,"accession":"0000950170-24-121742","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-121742","line_url":"/filing/0000950170-24-121742#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6606.0,"shares_display":"6,606","price_per_share":48.97,"price_display":"48.97","price_state":"stated","total_value":323495.82,"total_display":"323,495.82","total_whole":"323,496","shares_owned_after":5796.0,"shares_owned_after_display":"5,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"},{"id":2083161,"accession":"0000950170-24-112385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-112385","line_url":"/filing/0000950170-24-112385#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":46.28,"price_display":"46.28","price_state":"stated","total_value":462800.0,"total_display":"462,800.00","total_whole":"462,800","shares_owned_after":5796.0,"shares_owned_after_display":"5,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider"},{"id":2177793,"accession":"0000950170-24-104196","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-104196","line_url":"/filing/0000950170-24-104196#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.3,"price_display":"35.30","price_state":"stated","total_value":353000.0,"total_display":"353,000.00","total_whole":"353,000","shares_owned_after":6039.0,"shares_owned_after_display":"6,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"},{"id":3021391,"accession":"0000950170-24-091069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-091069","line_url":"/filing/0000950170-24-091069#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":38.67,"price_display":"38.67","price_state":"stated","total_value":386700.0,"total_display":"386,700.00","total_whole":"386,700","shares_owned_after":6039.0,"shares_owned_after_display":"6,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider"},{"id":3111457,"accession":"0000950170-24-081628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-081628","line_url":"/filing/0000950170-24-081628#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.49,"price_display":"32.49","price_state":"stated","total_value":324900.0,"total_display":"324,900.00","total_whole":"324,900","shares_owned_after":6039.0,"shares_owned_after_display":"6,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":3215174,"accession":"0000950170-24-069600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-069600","line_url":"/filing/0000950170-24-069600#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","total_whole":"320,000","shares_owned_after":6039.0,"shares_owned_after_display":"6,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2588570,"accession":"0000950170-24-066881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-066881","line_url":"/filing/0000950170-24-066881#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":960000.0,"total_display":"960,000.00","total_whole":"960,000","shares_owned_after":6039.0,"shares_owned_after_display":"6,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":7963560,"accession":"0000950170-23-072771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-072771","line_url":"/filing/0000950170-23-072771#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001879013","owner_name":"Guyer William","owner_display_name":"Guyer William","owner_url":"/insider/0001879013","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","total_whole":"320,000","shares_owned_after":6643.0,"shares_owned_after_display":"6,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":42,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":42,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":42},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001088856","name":"CORCEPT THERAPEUTICS INC","url":"/issuer/0001088856","role":"Officer (Chief Development Officer)","n_filings":33,"first_seen":"2023-12-22","last_seen":"2026-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001879013","retrieved_at":"2026-08-24T21:32:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}